Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis

A Booth, AB Reed, S Ponzo, A Yassaee, M Aral… - PloS one, 2021 - journals.plos.org
Aim COVID-19 clinical presentation is heterogeneous, ranging from asymptomatic to severe
cases. While there are a number of early publications relating to risk factors for COVID-19 …

Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease

EF Balcom, A Nath, C Power - Brain, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) is a global pandemic caused by SARS-CoV-
2 infection and is associated with both acute and chronic disorders affecting the nervous …

Acute ischemic stroke and COVID-19: an analysis of 27 676 patients

AI Qureshi, WI Baskett, W Huang, D Shyu, D Myers… - Stroke, 2021 - Am Heart Assoc
Background and Purpose: Acute ischemic stroke may occur in patients with coronavirus
disease 2019 (COVID-19), but risk factors, in-hospital events, and outcomes are not well …

Mechanisms of stroke in COVID-19

JD Spence, GR De Freitas, LC Pettigrew, H Ay… - Cerebrovascular …, 2020 - karger.com
In this Commentary, we address mechanisms of stroke in patients with coronavirus disease
2019 (COVID-19) due to infection with the severe acute respiratory syndrome coronavirus-2 …

Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: a systematic review, meta-analysis and call for action

L Liu, SY Ni, W Yan, QD Lu, YM Zhao, YY Xu… - …, 2021 - thelancet.com
Abstract Background Coronavirus disease 2019 (COVID-19) has evolved into a worldwide
pandemic, and has been found to be closely associated with mental and neurological …

Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist

A Zakeri, AP Jadhav, BA Sullenger… - Journal of …, 2021 - jnis.bmj.com
Coronavirus disease 2019 (COVID-19) results from infection by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). It was first reported in Wuhan, China in patients …

COVID-19 and risk of acute ischemic stroke and acute lung injury in patients with type ii diabetes mellitus: the anti-inflammatory role of metformin

HM Al-Kuraishy, AI Al-Gareeb, M Alblihed… - Frontiers in …, 2021 - frontiersin.org
Background: Coronavirus disease 19 (COVID-19) is regarded as an independent risk factor
for acute ischemic stroke (AIS) due to the induction of endothelial dysfunction, coagulopathy …

Exacerbation of neurological symptoms and COVID-19 severity in patients with preexisting neurological disorders and COVID-19: a systematic review

T Kubota, N Kuroda - Clinical Neurology and Neurosurgery, 2021 - Elsevier
Background Patients with chronic diseases likely develop severe 2019 coronavirus disease
(COVID-19). However, little is known about the effects of COVID-19 on patients with …

Vascular manifestations of COVID-19–thromboembolism and microvascular dysfunction

KA Roberts, L Colley, TA Agbaedeng… - Frontiers in …, 2020 - frontiersin.org
The coronavirus pandemic has reportedly infected over 31.5 million individuals and caused
over 970,000 deaths worldwide (as of 22nd Sept 2020). This novel coronavirus, officially …

Filling the gaps on stroke research: Focus on inflammation and immunity

D Levard, I Buendia, A Lanquetin, M Glavan… - Brain, behavior, and …, 2021 - Elsevier
For the last two decades, researchers have placed hopes in a new era in which a
combination of reperfusion and neuroprotection would revolutionize the treatment of stroke …